| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.71M | 12.73M | 15.94M | 32.66M | 49.75M |
| Gross Profit | 8.91M | 8.14M | 9.56M | 13.69M | 16.39M |
| EBITDA | 2.84M | 2.89M | 6.13M | 8.46M | 11.61M |
| Net Income | 2.06M | 2.00M | 4.82M | 6.16M | 8.45M |
Balance Sheet | |||||
| Total Assets | 24.39M | 23.03M | 27.64M | 29.45M | 33.92M |
| Cash, Cash Equivalents and Short-Term Investments | 19.85M | 18.57M | 21.19M | 11.06M | 9.21M |
| Total Debt | 811.46K | 725.40K | 1.42M | 1.47M | 3.94M |
| Total Liabilities | 4.97M | 3.82M | 5.82M | 6.90M | 12.89M |
| Stockholders Equity | 19.42M | 19.21M | 21.82M | 22.55M | 21.03M |
Cash Flow | |||||
| Free Cash Flow | 3.28M | 2.06M | 4.76M | 8.57M | 16.44M |
| Operating Cash Flow | 3.29M | 2.06M | 4.77M | 8.60M | 16.47M |
| Investing Cash Flow | 587.90K | 677.27K | 898.61K | 445.79K | 41.78K |
| Financing Cash Flow | -2.60M | -5.37M | 4.51M | -7.23M | -11.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$53.33B | 22.02 | 8.70% | 0.63% | 16.62% | 42.86% | |
71 Outperform | HK$37.95M | 9.11 | 15.10% | 6.25% | 14.68% | -4.55% | |
68 Neutral | HK$1.51B | 41.03 | 11.92% | 2.53% | 4.77% | 20.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$3.21B | 83.74 | -11.77% | 0.24% | 0.94% | ― | |
54 Neutral | HK$3.15B | -27.84 | -31.28% | ― | -34.98% | -3.65% | |
53 Neutral | HK$603.89M | -46.77 | -0.25% | ― | -7.14% | 85.97% |